Skip to main content
Erschienen in: BMC Gastroenterology 1/2023

Open Access 01.12.2023 | Research article

Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study

verfasst von: Severin A. Lautenschlager, Mamadou Pathé Barry, Gerhard Rogler, Luc Biedermann, Philipp Schreiner, Alexander R. Siebenhüner, Swiss IBD Cohort Study Group

Erschienen in: BMC Gastroenterology | Ausgabe 1/2023

Abstract

Background

Various environmental risk factors have been associated with the pathogenesis of inflammatory bowel disease. In this study we aimed to identify lifestyle factors that affect the onset of Crohn’s disease and ulcerative colitis.

Methods

2294 patients from the Swiss IBD Cohort Study received a questionnaire regarding physical activity, nutritional habits and status of weight. In addition, a control group was formed comprising patients’ childhood friends, who grew up in a similar environment.

Results

Overall, 1111 questionnaires were returned (response rate: 48.4%). Significantly more patients with inflammatory bowel disease reported no regular practice of sport during childhood and beginning of adulthood compared to the control group (p = 0.0001). No association between intake of refined sugar and onset of inflammatory bowel disease was observed. More patients with Crohn’s disease compared to ulcerative colitis and controls suffered from overweight during childhood (12.8% vs. 7.7% and 9.7%, respectively; p = 0.027).

Conclusions

Our study underlines the relevance of environmental factors in the development of inflammatory bowel disease. Our results imply a protective effect of physical activity regarding the onset of inflammatory bowel disease.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
IBD
Inflammatory bowel disease
CD
Crohn’s disease
C-section
Caesarean section
EF
Environmental factors
UC
Ulcerative colitis
IC
Indeterminate colitis
SIBDCS
Swiss inflammatory bowel disease cohort study
EIM
Extraintestinal manifestation
PSC
Primary sclerosing cholangitis

Introduction

Inflammatory bowel disease (IBD) is a chronic and relapsing inflammatory disorder of the gastrointestinal tract and includes the main subtypes Crohn’s disease (CD) and ulcerative colitis (UC). Incidence and prevalence of IBD in Western countries have been on the rise since the beginning of the twentieth century [1]. In developing countries, an increase of IBD incidence and prevalence occurred over the last 30 years, when Westernized lifestyle and dietary habits were adopted [2, 3]. A contribution of environmental factors to the rapid rise of IBD incidence is highly probable, considering that genetic susceptibility has been present in human beings since thousands of years without significant changes in this short period. Environmental risk factors, which affect the course of IBD are currently studied with epidemiological approaches and some influencing factors, such as breastfeeding, diet or antibiotic use have been identified [46].
Diet is widely considered as a key environmental factor. Dietary changes affect the composition of the gut microbiome, which may influence mechanisms of immunological tolerance [7, 8]. Western diet is mainly composed of high-sugar, low-fiber, animal-protein and fat, but low ingestion of vegetables [9, 10]. Epidemiological data suggest, that a ‘Westernization’ of the diet may induced mucosal inflammation in susceptible individuals and may act as promoter in the pathogenesis of IBD [11]. Recent data demonstrated a positive correlation between pro-inflammatory and ultra-processed food intake and the risk of developing IBD [12, 13].
The reason why a dysbiosis of the intestinal microbiota promotes the development of IBD is not fully understood. A plausible explanation is the increase in potentially pathogenic bacterial species combined with a decrease in protective bacteria, resulting a disruption of local immune homeostasis, increased mucosal permeability and loss of immune tolerance [14].
Literature data is scarce regarding the association between IBD and dietary behavior in the childhood period, considering that a subclinical intestinal inflammation can exist a long time before the outbreak of the disease [7]. In addition, not much is known about overweight in childhood and its influence on development of IBD or disease activity. Previous work implies an association between overweight and more severe disease activity in children with IBD [15].
Better knowledge regarding dietary habits would be of utmost importance for patients to reduce flare-ups, but also to prevent the development of IBD.
Likewise, breastfeeding and mode of delivery are considered as an important factor regarding the composition of the microbiome in the early childhood period and have been associated with the development of IBD [1618]. A review of Ananthakrishnan et al. [19] outlined a protective effect of being breastfed for IBD. Concerning the mode of delivery as a risk factor for IBD, findings in literature are inconsistent. While various studies postulated Caesarean section (C-section) as a risk factor for IBD, a population-based study of Bernstein et al. found no association between IBD and mode of delivery [16, 20, 21].
Physical activity levels have been associated as a protective factor regarding the risk of IBD due to a reduction of systemic inflammation [2226]. Physical activity has various effects on immunomodulatory processes and affects the balance of inflammatory and anti-inflammatory mechanisms [27, 28]. Investigations showed that incidence of autoimmune diseases such as rheumatoid arthritis, multiple sclerosis or psoriasis is higher in patients less engaged in physical activity [29].
According to present experience we have a lack of knowledge concerning nutrition and diet as well as physical activities among patient with IBD and their potential impact on disease development. Increased knowledge of early-life risk factors of IBD ensures better prevention of disease and may reduce the number of IBD patients.
Main goal of this study is to figure out the impact of lifestyle factors such as dietary habits, weight status and physical activity on IBD in Swiss patients, especially regarding childhood period and adolescence.

Materials and methods

Study design

Prospectively obtained data from patients of the Swiss IBD cohort study (SIBDCS), a nationwide cohort study funded by the Swiss National Science Foundation were analyzed. In addition to patients diagnosed with IBD, the cohort has included two related cohorts of patient’s friends and mothers to evaluate the impact of various environmental factors on IBD risk. Clinical and treatment data have been prospectively captured with a yearly follow-up and entered into a database since the establishment of the cohort in 2006. Purposes and methodology of SIBDC have been described elsewhere [30, 31].
Questionnaires regarding various environmental factors were distributed to IBD patients (n = 2294) between December 2015 and October 2016 in Swiss national languages. Questionnaires returned until January 2018 were included in this study. In addition, identical questionnaires were sent out to up to three matched childhood friends to form a control group (friend’s cohort), which had been exposed to a similar environment as the patients. To double-check information relating to patient’s early childhood period, a questionnaire addressing the patients’ mothers was sent out. Concerning potential influencing factors on IBD such as physical activity, overweight and obesity we focused on childhood period and beginning of adulthood.
Our intention was to obtain information from the point of birth to the age of about 4 years. In the interest of simplification, we defined this period in our questionnaires ‘first years of life’.
We further categorized sugary foods into sugary drinks (Coca-Cola, Fanta etc.), artificial sugary (jelly-babies, bonbons) and natural sugary (e.g. chocolate).

Statistical analysis

Statistical analyses were performed using the Version 16.0 of the Stata software (College Station, TX 77,845 USA) with univariate, bivariate and multivariate analysis. Univariate analyses were performed to summarize the variables and multivariate analysis was used to evaluate the impact of some explanatory variables on dietary habits. The qualitative variables were summarized with percentages and the quantitative variables with the mean and the standard deviation when they were normally distributed or with the median and the interquartile range when they were not. For bivariate analyses, the Chi-square test was performed to study the relationship between the categorical variables. We performed the Student test to compare the means between the groups when the variables are normally distributed. The Wilcoxon–Mann–Whitney test was used to compare the means when the variables are not normally distributed.

Results

Clinical characteristics of the study population

Out of 2294 questionnaires handed out to SIBDC patients, 1111 were sent back (response rate: 48.4%). Additional information from mother questionnaires were available for 305 out of 1111 responding patients (response rate: 27.5%). In addition, we obtained 225 questionnaires from at least one patients’ friend (Response rate: 20.3%). A total of 352 friends’ questionnaires were received.
Divided in subtypes, we received 610 questionnaires from patients with CD and 468 with UC/IC. For further clinical and epidemiological parameters of CD and UC/IC we refer to Table 1.
Table 1
Clinical characteristics of the study population
 
CD (n = 610)
UC/IC (n = 468)
Controls (n = 365)
p-value
Gender [n (%)]
    
  Male
271 (44.4%)
232 (49.6)
130 (35.6)
0.001
  Female
339 (55.6%)
236 (50.4)
235 (64.4)
 
Age [y]
48.5, 15.5
50, 14
36, 9
0.0001
  (Mean, SD, range)
18–87
19–85
18–75
 
BMI [kg/m2]
23.6, 3.6
24.5, 3.7
21.3, 3.1
0.224
  (Mean, SD, range)
18–30
18–31.5
18–25
 
Age at diagnosis [y]
31, 14
34, 14
 
0.0001
  (Mean, SD, range)
1–75
8–78
  
Disease duration [y]
18, 11
16, 10
 
0.0034
  (Mean, SD, range)
0–53
0–52
  
CDAI
20, 41
   
  (Median, IQR, range)
0–230
   
MTWAI
 
1, 3
  
  (Median, IQR, range)
 
0–17
  
Smoking status at diagnosis [n (%)]
    
  Non-smoker
350 (57.7)
371 (75.7)
 
0.001
  Smoker
235 (38.7)
93 (19)
  
  Unknown
22 (3.6)
26 (5.3)
  
Current smoking status [n (%)]
    
  Non-smoker
453 (74.6)
319 (85.5)
 
0.001
  Smoker
151 (24.9)
66 (13.5)
  
  Unknown
3 (0.5)
5 (1)
  
Therapy history (ever treated with) [n (%)]
    
  5-ASA
369 (60.8)
471 (96.0)
 
0.001
  Steroids
528 (87)
398 (81)
 
0.009
  Immunomodulators
492 (81.1)
300 (61.2)
 
0.001
  Anti-TNF
384 (63.3)
169 (34.5)
 
0.001
EIM [n (%)]
    
  Any
380 (62.6)
219 (44.7)
 
0.001
  Arthritis
330 (54.4)
173 (35.3)
 
0.001
  Uveitis/Iritis
79 (13)
30 (6.1)
 
0.001
  Pyoderma gangraenosum
8 (1.3)
9 (1.8)
 
0.489
  Erythema nodosum
62 (10.2)
15 (3.1)
 
0.001
  Aphtous/Oral ulcers
93 (15.3)
25 (5.1)
 
0.001
  Ankylosing spondylitis
38 (6.3)
16 (3.3)
 
0.023
  PSC
8 (1.3)
15 (3.1)
 
0.045
Complications [n (%)]
    
  Perianal fistula
164 (27)
  
  Other fistula
111 (18.3)
   
  Abscess
137 (22.6)
   
  Stenosis
264 (43.5)
   
Surgery history [n (%)]
    
  Any
313 (51.6)
53 (10.8)
 
0.001
  Intestinal surgery
258 (42.5)
46 (9.4)
 
0.001
  Fistulas or abscess surgery
147 (24.2)
10 (2)
 
0.001
All tests were two-sided, with a P value of less than 0.05 considered to indicate statistical significance. These results are highlighted in bold

Physical activity during childhood and beginning of adulthood

For the period of childhood to the begin of adulthood, the report for 257 (42.1%) patients with CD and 181 (38.7%) patients with UC/IC presented no regular activity, whereas only 107 (29.3%) persons from the control group did not practice sport regularly (p = 0.001) (Table 2). More individuals from the control group (179, 49%) practiced sport alone or in a club, than patients with CD (248, 40.7%) or UC/IC (197, 42.1%, p = 0.032). There was a trend that more UC/IC patients (43, 9.2%) practiced frequently high-level sport than CD patients (34, 5.6%, p = 0.051). Regarding practicing endurance sport no difference between IBD patients and individuals from the control group was observed.
Table 2
Physical activity during childhood and beginning of adulthood
 
CD (n = 610)
UC/IC (n = 468)
Controls (n = 365)
p-value CD versus UC/IC
p-value IBD versus controls
Regular practice of sport [n (%)]
     
  Yes
353 (57.9)
287 (61.3)
258 (70.7)
0.252
0.001
  No
257 (42.1)
181 (38.7)
107 (29.3)
  
Regular practice of sport alone or in a club [n (%)]
     
  Yes
248 (40.7)
197 (42.1)
179 (49)
0.635
0.032
  No
362 (59.3)
271 (57.9)
186 (51)
  
Practice sport more than people in the same age [n (%)]
     
  Yes
65 (10.7)
49 (10.5)
51 (14)
0.922
0.210
  No
545 (89.3)
419 (89.5)
314 (86)
  
High level practice of sport frequently [n (%)]
     
  Yes
34 (5.6)
43 (9.2)
32 (8.8)
0.051
0.491
  No
576 (94.4)
425 (90.8)
333 (91.2)
  
Endurance sport [n (%)]
     
  Yes
2 (0.3)
3 (0.6)
4 (1.1)
0.453
0.337
  No
608 (99.7)
465 (99.4)
361 (98.9)
  
All tests were two-sided, with a P value of less than 0.05 considered to indicate statistical significance. These results are highlighted in bold

Breastfeeding and mode of birth

A higher number of individuals from the control group (243, 68.1%) had been breastfed as compared to patients with IBD, especially with IC/UC (279, 59.9%, p = 0.002) (Table 3). Significantly more persons from the control group reported that their baby bottles and teats had been sterilized (139, 43.8%) compared to IBD patients (CD: 172, 32.6%, UC/IC: 127, 31.4%). The number of individuals from the control group born by C-section (50, 13.7%) was significantly higher than in the IBD group (p = 0.001). Premature birth has significantly more often occurred in the CD fraction (61, 10.2%) than in the control group (28, 7.8%).
Table 3
Breastfeeding and mode of birth
 
CD (n = 610)
UC/IC (n = 468)
Controls (n = 365)
p-value CD versus UC/IC
p-value IBD versus controls
Have you been breastfed [n (%)]
     
  Yes
398 (65.7)
279 (59.9)
243 (68.1)
0.033
0.002
  No
105 (17.3)
112 (24)
81 (22.7)
 
  Don’t know
103 (17)
74 (15.9)
32 (9)
 
  Missing
4
3
9
 
Sterilization of baby bottles and teats [n (%)]
     
  Yes
172 (32.6)
127 (31.4)
139 (43.8)
0.284
0.001
  No
62 (11.7)
35 (8.6)
49 (15.5)
 
  Don’t know
293 (55.5)
243 (60)
129 (40.7)
 
  Missing
82
63
48
 
Sterilization frequency of baby bottles and teats [n (%)]
     
  After each meal
45 (11.5)
30 (9.7)
40 (17.5)
0.781
0.021
  Once a day
45 (11.5)
40 (13)
42 (18.4)
 
  Once per week
19 (5)
17 (5.5)
12 (5.3)
 
  Don’t know
283 (72)
221 (71.8)
134 (58.8)
 
  Missing
218
160
137
 
Mode of birth
     
  Natural childbirth [n (%)]
495 (81.2)
389 (83.1)
291 (79.3)
0.403
0.446
  Caesarean-section [n (%)]
49 (8)
28 (6)
50 (13.7)
0.195
0.001
  Forceps delivery [n (%)]
14 (2.3)
13 (2.8)
6 (1.6)
0.615
0.554
  Delivery with cupping [n (%)]
13 (2.1)
17 (3.6)
10 (2.7)
0.137
0.330
  I don’t know [n (%)]
37 (6.1)
22 (4.7)
7 (1.9)
  
Are you born at term [n (%)]
     
  Yes
423 (70.7)
349 (75.2)
268 (74.4)
0.111
0.017
  Premature birth
61 (10.2)
30 (6.5)
28 (7.8)
 
  Birth triggered after the term
37 (6.2)
19 (4.1)
32 (8.9)
 
  Don’t know
75 (12.5)
64 (13.8)
32 (9)
 
  Missing
14
6
5
 
All tests were two-sided, with a P value of less than 0.05 considered to indicate statistical significance. These results are highlighted in bold

Dietary habits

Significantly more individuals from the control group (187, 51.2%) reported they had drunk packet cow milk from the supermarket during the first years of life than IBD patients (p = 0.001) (Table 4). On the other hand, more patients suffering from IBD (CD: 158, 25.9%, UC/IC: 118, 25.2%) drank cow milk directly from the farm during the first years of life than exponents from the control group (62, 17%, p = 0.003). Concerning the kind of milk there were slightly more individuals from the controls (53, 14.5%) who drank semi-skimmed milk during the first years of life than patients diagnosed with IBD (CD: 57, 9.3%, UC/IC: 49, 10.5%). Comparing other kind of milk between controls and IBD patients showed no significant difference.
Table 4
Nutritional habits during the first years of life
 
CD (n = 610)
UC/IC (n = 468)
Controls (n = 365)
p-value CD versus UC/IC
p-value IBD versus controls
Did you regularly drink cow’s milk during the first years of your life
     
  Packed (super market) [n (%)]
208 (34.1)
145 (31)
187 (51.2)
0.280
0.001
  Directly from the farm [n (%)]
158 (25.9)
118 (25.2)
62 (17)
0.798
0.003
  Yes one or the other [n (%)]
92 (15.1)
81 (17.3)
58 (15.9)
0.324
0.612
  No [n (%)]
38 (6.2)
32 (6.8)
18 (4.9)
0.688
0.514
I don’t know [n (%)]
115 (18.8)
94 (20.1)
39 (10.7)
  
What kind of milk did you drink in the first years
     
  Whole milk 3.5% fat [n (%)]
305 (50)
249 (53.2)
198 (54.3)
0.297
0.371
  Semi-skimmed milk 1.5% fat [n (%)]
57 (9.3)
49 (10.5)
53 (14.5)
0.538
0.04
  Skimmed milk < 0.3% [n (%)]
5 (0.8)
4 (0.9)
4 (1.1)
0.950
0.900
  Raw milk [n (%)]
88 (14.4)
78 (16.7)
51 (14)
0.312
0.478
  Milk without lactose [n (%)]
3 (0.5)
0
0
0.129
0.128
  Soy milk [n (%)]
3 (0.5)
2 (0.4)
4 (1.1)
0.877
0.412
  I don’t know [n (%)]
158 (26)
110 (23.8)
69 (19.1)
  
Did you tolerate the milk well
     
  Yes [n (%)]
398 (65.3)
343 (73.3)
279 (76.4)
0.005
0.001
  No [n (%)]
131 (21.5)
74 (15.8)
62 (17)
0.019
0.041
  I don’t know [n (%)]
73 (12)
44 (9.4)
17 (4.7)
  
What are the symptoms that you had after consuming milk
     
  Bloating [n (%)]
60 (9.8)
37 (7.9)
32 (8.8)
0.272
0.541
  Pain [n (%)]
29 (4.7)
17 (3.6)
11 (3)
0.366
0.367
  Diarrhea [n (%)]
63 (10.3)
21 (4.5)
19 (5.2)
0.001
0.001
  Nausea [n (%)]
30 (4.9)
15 (3.2)
17 (4.7)
0.163
0.360
  Other [n (%)]
83 (13.6)
62 (13.3)
34 (9.3)
0.864
0.115
  I don’t know [n (%)]
90 (14.8)
64 (13.7)
24 (6.6)
  
All tests were two-sided, with a P value of less than 0.05 considered to indicate statistical significance. These results are highlighted in bold
279 out of 365 controls (76.4%) reported they had tolerated the milk well during the first years of life, while significant less patients suffering from IBD tolerated the milk well (p = 0.001). Comparing the subgroups of IBD there were significant more patients with CD (131, 21.5%) complaining about symptoms after drinking milk in the first years of life than patients with UC/IC (74, 15.8%, p = 0.019). When investigating the several symptoms in more detail a higher number of CD patients (63, 10.3%) complained about diarrhea during the first years of life after drinking milk than patients suffering from UC (21, 4.5%, p = 0.001) and controls (19, 5.2%).
When observing the analysis of eating behavior of sugary foods until the age of 18 years no significant differences between IBD patients and controls stood out (Table 5). Regardless of the stage of life more patients diagnosed with IBD (CD: 24, 3.9%, UC/IC: 17, 3.6%) reported to feed their selves on a vegetarian basis than individuals from the control group (Table 6). In addition, more patients diagnosed with CD (88, 14.4%) consumed a meat-rich diet than patients with UC/IC (40, 8.6%, p = 0.003) and controls (39, 10.7%) Considering other special diets such as gluten free or vegan alimentation no significant difference between IBD patients and controls has been observed.
Table 5
Sugary foods until the age of 18
 
CD (n = 610)
UC/IC (n = 468)
Controls (n = 365)
p-value CD versus UC/IC
p-value IBD versus controls
Sugary drinks [n (%)]
     
  More than other children
24 (4.1)
21 (4.6)
13 (3.6)
0.716
0.906
  In average like other children
285 (48.1)
229 (50)
176 (48.8)
 
  Less than other children
283 (47.8)
208 (45.4)
172 (47.7)
 
  Missing
18
10
4
 
Eating artificial sugary [n (%)]
     
  More than other children
33 (5.7)
25 (5.5)
18 (5)
0.765
0.278
  In average like other children
280 (48)
228 (50)
203 (56.2)
 
  Less than other children
269 (46.1)
203 (44.5)
140 (38.8)
 
  Missing
27
12
4
 
Eating natural sugary [n (%)]
     
  More than other children
54 (9.2)
45 (9.8)
36 (9.9)
0.720
0.427
  In average like other children
406 (69.1)
324 (70.4)
266 (73.5)
 
  Less than other children
128 (21.8)
91 (19.8)
60 (16.6)
 
  Missing
22
8
1
 
Table 6
Eating habits or special diets
 
CD (n = 610)
UC/IC (n = 468)
Controls (n = 365)
p-value CD versus UC/IC
p-value IBD versus controls
Consuming food like the average [n (%)]
     
  Yes
504 (82.6)
401 (85.7)
303 (83.1)
0.175
0.369
  No
106 (17.4)
67 (14.3)
62 (17)
  
Vegetarian alimentation [n (%)]
     
  Yes
24 (3.9)
17 (3.6)
30 (8.2)
0.797
0.003
  No
586 (96.1)
451 (96.4)
335 (91.8)
  
Vegan alimentation [n (%)]
     
  Yes
2 (0.3)
4 (0.9)
4 (1.0)
0.249
0.329
  No
608 (99.7)
464 (99.1)
361 (98.9)
  
Gluten free [n (%)]
     
  Yes
12 (2)
10 (2.1)
5 (1.4)
0.845
0.701
  No
598 (98)
458 (98)
360 (98.6)
  
Low-lactose or lactose free [n (%)]
     
  Yes
42 (6.9)
27 (5.8)
16 (4.4)
0.458
0.273
  No
568 (93.1)
441 (94.2)
349 (95.6)
  
Fastfood or finished products more than 3 times a week [n (%)]
     
  Yes
8 (1.3)
8 (1.7)
3 (0.8)
0.592
0.537
  No
602 (98.7)
460 (98.3)
362 (99.2)
  
Meat-rich diet [n (%)]
     
  Yes
88 (14.4)
40 (8.6)
39 (10.7)
0.003
0.009
  No
522 (85.6)
428 (91.5)
326 (89.3)
  
All tests were two-sided, with a P value of less than 0.05 considered to indicate statistical significance. These results are highlighted in bold

Overweight or obesity during childhood and beginning of adulthood

One hundred and four out of 610 patients with CD (17.2%) reported they had insufficient weight or were very thin during childhood compared to children of their age (Table 7). Compared with the controls (35, 9.7%) and patients diagnosed with UC/IC (36, 7.7%, p = 0.027) significantly more patients with CD suffered from overweight during childhood (77, 12.8%, p = 0.012).
Table 7
Overweight or obesity during childhood and beginning of adulthood compared to children of their age
 
CD (n = 610)
UC/IC (n = 468)
Controls (n = 365)
p-value CD versus UC/IC
p-value IBD versus controls
During childhood [n (%)]
     
  Insufficient weight/very thin
104 (17.2)
77 (16.5)
54 (14.9)
0.027
0.012
  Weight in the average
410 (67.9)
341 (73.2)
268 (74)
  Overweight, round, coated
77 (12.8)
36 (7.7)
35 (9.7)
  Obese
5 (0.8)
0
5 (1.4)
  I don’t know
7 (1.2)
9 (2)
0
  Missing
7
6
3
At the beginning of adulthood [n (%)]
     
  Insufficient weight/very thin
102 (16.9)
56 (12.1)
35 (9.7)
0.027
0.014
  Weight in the average
441 (73.3)
376 (81)
287 (79.3)
  Overweight, round, coated
53 (8.8)
28 (6)
37 (10.2)
  Obese
4 (1)
2 (0.4)
3 (0.8)
  Missing
8
6
3
All tests were two-sided, with a P value of less than 0.05 considered to indicate statistical significance. These results are highlighted in bold
Similarly, at beginning of adulthood, more CD patients (102, 16.9%) had insufficient weight or were very thin than UC/IC patients (56, 12.1%, p = 0.027) or controls (35, 9.7%). In contrary to the childhood period, controls (37, 10.2%) tended to have more overweight than patients with CD (58, 8.8%) and UC/IC (28, 6%).

Discussion

Based on 1111 questionnaires of IBD patients we aimed to identify associations between environmental factors and the development of IBD. Our data confirm physical activity as a protective factor for IBD. Consuming meat-rich diet was associated with developing CD. On the other hand, no correlation between intake of sugar and development of IBD was observed. Overweight during childhood was associated for CD, but not for UC. Underweight during childhood and adulthood was associated with both, CD and UC/IC.
Our results support the hypothesis of a protective effect of physical activity regarding the development of IBD. Patients diagnosed with IBD reported to be less physically active during childhood and beginning of adulthood than persons from the control group. These findings are in line with the result of a review of meta-analyses recently published, that demonstrated a protective effect of physical activity regarding the development of CD [32]. On the other hand, a Danish prospective cohort study reported no association between physical activity and risk of IBD [33]. A possible explanation for this discrepancy to our result is, that the Danish study did not investigate the association between timing in life of physical activity and risk of IBD. The influence of physical activity on the onset of IBD is still unclear and evidence in literature is scarce. There is consensus in literature that physical activity has an impact on various aspects of the immune system and autoimmune diseases [29]. An investigation of Steensberg et al. [34] implied that sporting activity induces a shift in the Th1/Th2 balance to a decrease in Th1 cells. Th1 is responsible for secretion of proinflammatory cytokines as IL-1, IL-2, IL-6 and IL-8, whereas anti-inflammatory cytokines as IL-4, IL-10 and IL-13 are secreted by Th2 cells. Thus, the balance between proinflammatory and anti-inflammatory mechanisms is highly affected by the Th1/Th2 cells ratio and responsible for the types of immune responses that patients develop [35]. Considering other diseases driven by autoimmune processes such as rheumatoid arthritis, multiple sclerosis or psoriasis, studies have shown an increased incidence in patients less engaged in physical activity [29].
Lack of exercise may result in obesity, what is assumed to be a cause for a chronic low-grade inflammation in humans [36]. It is explained, amongst others, by a predominance of pro-inflammatory macrophages in mesenteric visceral adipose tissue, that is responsible for secretion of various inflammatory cytokines, including IL-1 and TNF [37]. Kugathasan et al. [38] demonstrated that about 9–10% of children with CD and 20–34% of children with UC had an increased BMI above the 85th percentile at diagnosis. In contrary, a recently published study demonstrated no worsened disease activity 1 year after diagnosis of IBD of overweight children compared with normal weight children [39]. Our patients with CD reported to be more often overweight compared to children of their age during childhood. Both, CD and UC patients reported to be underweighted compared to children of their age during childhood and adulthood. A recently published meta-analysis reported an positive association between underweight and the onset of CD, but not for UC [40].
The impact of breastfeeding on the onset of IBD is also under debate. Previous trials demonstrated that alteration in the composition of the microbiota disrupts microbial mediated mechanisms of immunological tolerance [7, 8]. Human milk contains, among others, oligosaccharides with prebiotic effects including growth of Bifidobacteria which may affect the intestinal flora and influence the risk of IBD [41]. Our data support the assumption of a protective effect of breastfeeding, especially considering the onset of UC/IC. Furthermore, our attempt was to obtain information regarding breast milk substitution and identify bottle-feeding and frequency of sterilization of baby bottles and teats as possible risk factors for IBD. Investigations suggest a positive association of breastfeeding and development of IBD, but some controversy remains in literature [6, 17, 42]. Unfortunately, most of patients, friends and mothers had to answer the questions in this part with ‘don’t know’, whereby the data is not conclusive. Therefore, additional investigations are warranted.
Our findings do not support the thesis that C-section enhances the risk of IBD, as more persons from the control group reported to be born via C-section. Confounders may distort the result and the findings have to be treated with caution. A population-based analysis of Bernstein reported no association of C-section and IBD [21]. On the other hand a meta-analysis by Li et al. [16] indicated an increased risk for CD but not for UC after Cesarean delivery.
Interestingly, significantly more patients with CD than persons from the control group reported to be born prematurely. Although perinatal mortality has been considerably reduced during the past years, prematurely born infants are still liable to a higher mortality and morbidity rate in comparison with infants born at term [43]. These finding are in line with a work of Sonntag et al. [44] that identified preterm birth as a risk factor for CD.
Investigations suggest that diet plays an important role in IBD. Dietary habits have been changed in the western world during recent decades and cause alterations in the composition of the gut microbiota, that may result in aberrant intestinal immune response [45, 46]. A subclinical intestinal inflammation can be present long before occurrence of the first IBD symptoms [7]. For this reason, it is of utmost importance to identify risk factors that affected patients before the clinically manifest disease. Our data indicate that more people from the control group consumed semi-skimmed milk (1.5% fat) during the first years of life than patients with IBD. It has been shown that high fat intakes cause an accumulation of secondary bile acids, what is responsible for reduction in growths of Firmicutes phyla and Bacteroidetes, both associated with IBD-like dysbiosis [47]. On the other hand, a prospective study of Ananthakrishnan et al. [48] indicated no association of fat consumption and IBD in women. Interestingly, patients diagnosed with CD reported to have had a milk intolerance during their first years of life, clinically characterized by diarrhea. A positive correlation between IBD and lactose intolerance is well established in literature, but evidence is scarce that a milk intolerance might be already present during the first years of life and a long time before the diagnosis of the disease [49]. The association between sugar intake and risk of IBD remains controversial. Several studies showed a negative effect of consuming sugary food on the onset of IBD [5052]. In contrast to these findings, a large prospective study could not identify sugar intake as a risk factor for developing UC [53]. Our data suggest no connection between IBD and eating of neither artificial nor natural sugary until the age of 18. Literature is very scarce regarding dietary habits before 18 and development of IBD. Ananthakrishnan et al. [54] published an investigation regarding high school diet and risk of CD and UC, which demonstrated no association between intake of carbohydrates and onset of IBD.
Previous studies have shown a correlation between diet rich in animal protein and development of IBD [55, 56]. Our data support these findings and we report that statistically significant more CD patients consume meat-rich diet in comparison to the control group. A plausible explanation is that high intake of protein result in increased production of potentially toxic bacterial metabolites, what may lead to an impaired epithelial repair process [57]. As well, our data implicate a reduced consumption of vegetarian alimentation in IBD patients, what confirms the assumption that diets in high animal proteins lead to increased risk of IBD.
Our study has strengths as well as weaknesses. A strength is the large amount of IBD patients in our cohort with in total 1111 returned questionnaires. Furthermore, we aimed to reduce the ‘recall bias’ due to 305 returned questionnaires from patients’ mothers.
One limitation is the low overall return of questionnaires. The low response rate of the patient’s friends resulted in a small control group compared to the large number of IBD patients. Probably it was more difficult than expected for patients to reach childhood friends who grew up in a similar environment. Even though a high response rate is preferable, previous studies could demonstrate that there is no evidence of more accurate measurement in surveys with higher response rates [58, 59].
Furthermore, we are aware that our methodology is of risk of ‘recall bias’. Even though the data of patient’s mothers reduce the ‘recall bias’, incorrect memories of behavior during childhood may exist. To confirm our findings further prospective randomised trials are needed. As well, our analyses were not matched for potential confounders. We performed a multivariate analysis included all the investigated risk factors matched for sex, age and smoking status. As there was no significant difference in the results to our published data, we decided to exclude the multivariate analysis.
In conclusion, our data demonstrate the possibility that lifestyle factors such as physical activity, dietary habits and weight status affect the onset of IBD and may play a crucial role in preventing IBD (Table 8). This study indicates that education and prevention strategies may reduce the increasing incidence of patients with inflammatory bowel disease.
Table 8
Overview of the most important findings regarding effects in regard to the development of CD and UC/IC (Statistical analyses are seen in Tables 2, 3, 4, 5, 6, 7)
Environmental factor
CD
UC/IC
Physical activity
Protective
Protective
Breastfeeding
No significant effect
Protective
Premature birth
Negative effect
No significant effect
Sugar intake
No significant effect
No significant effect
Meat-rich diet
Negative effect
No significant effect
Vegan-/vegetarian alimentation, gluten free diet,
No conclusive data
No conclusive data
Overweight during childhood
Negative effect
No significant effect
Underweight during childhood and adulthood
Negative effect
Risk factor

Acknowledgements

We wish to thank all the IBD patients, their mothers and friends for completing the questionnaires.
Members of the SIBDCS Study Group: Karim Abdelrahman, Gentiana Ademi, Patrick Aepli, Amman Thomas, Claudia Anderegg, Anca-Teodora Antonino, Eva Archanioti, Eviano Arrigoni, Diana Bakker de Jong, Bruno Balsiger, Polat Bastürk, Peter Bauerfeind, Andrea Becocci, Dominique Belli, José M. Bengoa, Luc Biedermann, Janek Binek, Mirjam Blattmann, Stephan Boehm, Tujana Boldanova, Jan Borovicka, Christian P. Braegger, Stephan Brand, Lukas Brügger, Simon Brunner, Patrick Bühr, Bernard Burnand, Sabine Burk, Emanuel Burri, Sophie Buyse, Dahlia-Thao Cao, Ove Carstens, Dominique H. Criblez, Sophie Cunningham, Fabrizia D’Angelo, Philippe de Saussure, Lukas Degen, Joakim Delarive, Christopher Doerig, Barbara Dora, Susan Drerup, Mara Egger, Ali El-Wafa, Matthias Engelmann, Jessica Ezri, Christian Felley, Markus Fliegner, Nicolas Fournier, Montserrat Fraga, Yannick Franc, Pascal Frei, Remus Frei, Michael Fried, Florian Froehlich, Raoul Ivano Furlano, Luca Garzoni, Martin Geyer, Laurent Girard, Marc Girardin, Delphine Golay, Ignaz Good, Ulrike Graf Bigler, Beat Gysi, Johannes Haarer, Marcel Halama, Janine Haldemann, Pius Heer, Benjamin Heimgartner, Beat Helbling, Peter Hengstler, Denise Herzog, Cyrill Hess, Roxane Hessler, Klaas Heyland, Thomas Hinterleitner, Claudia Hirschi, Petr Hruz, Pascal Juillerat, Carolina Khalid-de Bakker, Stephan Kayser, Céline Keller, Christina Knellwolf -Grieger, Christoph Knoblauch, Henrik Köhler, Rebekka Koller, Claudia Krieger -Grübel, Patrizia Künzler, Rachel Kusche, Frank Serge Lehmann, Andrew Macpherson, Michel H. Maillard, Michael Manz, Astrid Marot, Rémy Meier, Christa Meyenberger, Pamela Meyer, Pierre Michetti, Benjamin Misselwitz, Patrick Mosler, Christian Mottet, Christoph Müller, Beat Müllhaupt, Leilla Musso, Michaela Neagu, Cristina Nichita, Jan Niess, Andreas Nydegger, Nicole Obialo, Diana Ollo, Cassandra Oropesa, Ulrich Peter, Daniel Peternac, Laetitia Marie Petit, Valérie Pittet, Daniel Pohl, Marc Porzner, Claudia Preissler, Nadia Raschle, Ronald Rentsch, Alexandre Restellini, Sophie Restellini, Jean-Pierre Richterich, Frederic Ris, Branislav Risti, Marc Alain Ritz, Gerhard Rogler, Nina Röhrich, Jean-Benoît Rossel, Vanessa Rueger, Monica Rusticeanu, Markus Sagmeister, Gaby Saner, Bernhard Sauter, Mikael Sawatzki, Michael Scharl, Martin Schelling, Susanne Schibli, Hugo Schlauri, Dominique Schluckebier, Daniela Schmid, Sybille Schmid -Uebelhart, Jean-François Schnegg, Alain Schoepfer, Vivianne Seematter, Frank Seibold, Mariam Seirafi, Gian-Marco Semadeni, Arne Senning, Christiane Sokollik, Joachim Sommer, Johannes Spalinger, Holger Spangenberger, Philippe Stadler, Peter Staub, Dominic Staudenmann, Volker Stenz, Michael Steuerwald, Alex Straumann, Bruno Strebel, Andreas Stulz, Michael Sulz, Aurora Tatu, Michela Tempia-Caliera, Joël Thorens, Kaspar Truninger, Radu Tutuian, Patrick Urfer, Stephan Vavricka, Francesco Viani, Jürg Vögtlin, Roland Von Känel, Dominique Vouillamoz, Rachel Vulliamy, Paul Wiesel, Reiner Wiest, Stefanie Wöhrle, Samuel Zamora, Silvan Zander, Tina Wylie, Jonas Zeitz, Dorothee Zimmermann.

Declarations

The questionnaire and methodology for this study were performed in line with principles of the Declaration of Helsinki. The SIBDCS study protocol has been approved by the cantonal ethics committee of Zurich (EK13-16). All patients provided written informed consent for participation in SIBDC and data collection. As well, mothers and friends signed informed consent forms prior to filling the respective questionnaires.
Not applicable.

Competing interests

Luc Biedermann reports fees for consulting/advisory board from Abbvie, MSD, Vifor, Falk, Esocap, Calypso, Ferring, Pfizer, Shire, Takeda, Janssen, Sanofi, Ewopharma. Philipp Schreiner received consulting fees from Pfizer, Takeda and Janssen-Cilag and travel support from Falk, UCB, Abbvie and Pfizer. All other authors have nothing to disclose.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.CrossRefPubMed Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.CrossRefPubMed
2.
Zurück zum Zitat Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145(1):158-65.e2.CrossRefPubMed Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145(1):158-65.e2.CrossRefPubMed
3.
Zurück zum Zitat Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504–17.CrossRefPubMed Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504–17.CrossRefPubMed
4.
Zurück zum Zitat Ananthakrishnan AN, Khalili H, Konijeti GG, et al. A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology. 2013;145(5):970–7.CrossRefPubMed Ananthakrishnan AN, Khalili H, Konijeti GG, et al. A prospective study of long-term intake of dietary fiber and risk of Crohn’s disease and ulcerative colitis. Gastroenterology. 2013;145(5):970–7.CrossRefPubMed
5.
Zurück zum Zitat Ungaro R, Bernstein CN, Gearry R, et al. Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol. 2014;109(11):1728–38.CrossRefPubMed Ungaro R, Bernstein CN, Gearry R, et al. Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis. Am J Gastroenterol. 2014;109(11):1728–38.CrossRefPubMed
6.
Zurück zum Zitat Xu L, Lochhead P, Ko Y, et al. Systematic review with meta-analysis: breastfeeding and the risk of Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;46(9):780–9.PubMedCentralCrossRefPubMed Xu L, Lochhead P, Ko Y, et al. Systematic review with meta-analysis: breastfeeding and the risk of Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther. 2017;46(9):780–9.PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Rogler G, Vavricka S. Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD. Inflamm Bowel Dis. 2015;21(2):400–8.CrossRefPubMed Rogler G, Vavricka S. Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD. Inflamm Bowel Dis. 2015;21(2):400–8.CrossRefPubMed
8.
Zurück zum Zitat Noverr MC, Huffnagle GB. The “microflora hypothesis” of allergic diseases. Clin Exp Allergy. 2005;35(12):1511–20.CrossRefPubMed Noverr MC, Huffnagle GB. The “microflora hypothesis” of allergic diseases. Clin Exp Allergy. 2005;35(12):1511–20.CrossRefPubMed
9.
Zurück zum Zitat Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563–73.CrossRefPubMed Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563–73.CrossRefPubMed
10.
Zurück zum Zitat Dixon LJ, Kabi A, Nickerson KP, et al. Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis. 2015;21(4):912–22.CrossRefPubMed Dixon LJ, Kabi A, Nickerson KP, et al. Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis. 2015;21(4):912–22.CrossRefPubMed
11.
Zurück zum Zitat Khalili H, Chan SSM, Lochhead P, et al. The role of diet in the aetiopathogenesis of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2018;15(9):525–35.PubMedCentralCrossRefPubMed Khalili H, Chan SSM, Lochhead P, et al. The role of diet in the aetiopathogenesis of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2018;15(9):525–35.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Narula N, Wong ECL, Dehghan M, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021;374: n1554.PubMedCentralCrossRefPubMed Narula N, Wong ECL, Dehghan M, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ. 2021;374: n1554.PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Lo CH, Lochhead P, Khalili H, et al. Dietary inflammatory potential and risk of Crohn’s disease and ulcerative colitis. Gastroenterology. 2020;159(3):873-83.e1.CrossRefPubMed Lo CH, Lochhead P, Khalili H, et al. Dietary inflammatory potential and risk of Crohn’s disease and ulcerative colitis. Gastroenterology. 2020;159(3):873-83.e1.CrossRefPubMed
14.
Zurück zum Zitat Brown K, DeCoffe D, Molcan E, et al. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012;4(8):1095–119.PubMedCentralCrossRefPubMed Brown K, DeCoffe D, Molcan E, et al. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012;4(8):1095–119.PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Yerushalmy-Feler A, Ben-Tov A, Weintraub Y, et al. High and low body mass index may predict severe disease course in children with inflammatory bowel disease. Scand J Gastroenterol. 2018;53(6):708–13.CrossRefPubMed Yerushalmy-Feler A, Ben-Tov A, Weintraub Y, et al. High and low body mass index may predict severe disease course in children with inflammatory bowel disease. Scand J Gastroenterol. 2018;53(6):708–13.CrossRefPubMed
16.
Zurück zum Zitat Li Y, Tian Y, Zhu W, et al. Cesarean delivery and risk of inflammatory bowel disease: a systematic review and meta-analysis. Scand J Gastroenterol. 2014;49(7):834–44.CrossRefPubMed Li Y, Tian Y, Zhu W, et al. Cesarean delivery and risk of inflammatory bowel disease: a systematic review and meta-analysis. Scand J Gastroenterol. 2014;49(7):834–44.CrossRefPubMed
17.
Zurück zum Zitat Biedermann L, Rogler G, Vavricka SR, et al. Pregnancy and breastfeeding in inflammatory bowel disease. Digestion. 2012;86(Suppl 1):45–54.CrossRefPubMed Biedermann L, Rogler G, Vavricka SR, et al. Pregnancy and breastfeeding in inflammatory bowel disease. Digestion. 2012;86(Suppl 1):45–54.CrossRefPubMed
18.
Zurück zum Zitat Tamburini S, Shen N, Wu HC, et al. The microbiome in early life: implications for health outcomes. Nat Med. 2016;22(7):713–22.CrossRefPubMed Tamburini S, Shen N, Wu HC, et al. The microbiome in early life: implications for health outcomes. Nat Med. 2016;22(7):713–22.CrossRefPubMed
19.
Zurück zum Zitat Ananthakrishnan AN, Bernstein CN, Iliopoulos D, et al. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15(1):39–49.CrossRefPubMed Ananthakrishnan AN, Bernstein CN, Iliopoulos D, et al. Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 2018;15(1):39–49.CrossRefPubMed
20.
Zurück zum Zitat Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107(26):11971–5.PubMedCentralCrossRefPubMed Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107(26):11971–5.PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Bernstein CN, Banerjee A, Targownik LE, et al. Cesarean section delivery is not a risk factor for development of inflammatory bowel disease: a population-based analysis. Clin Gastroenterol Hepatol. 2016;14(1):50–7.CrossRefPubMed Bernstein CN, Banerjee A, Targownik LE, et al. Cesarean section delivery is not a risk factor for development of inflammatory bowel disease: a population-based analysis. Clin Gastroenterol Hepatol. 2016;14(1):50–7.CrossRefPubMed
22.
Zurück zum Zitat Khalili H, Ananthakrishnan AN, Konijeti GG, et al. Physical activity and risk of inflammatory bowel disease: prospective study from the nurses’ health study cohorts. BMJ. 2013;347: f6633.PubMedCentralCrossRefPubMed Khalili H, Ananthakrishnan AN, Konijeti GG, et al. Physical activity and risk of inflammatory bowel disease: prospective study from the nurses’ health study cohorts. BMJ. 2013;347: f6633.PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Hlavaty T, Toth J, Koller T, et al. Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: a Slovak case-control study. United Eur Gastroenterol J. 2013;1(2):109–19.CrossRef Hlavaty T, Toth J, Koller T, et al. Smoking, breastfeeding, physical inactivity, contact with animals, and size of the family influence the risk of inflammatory bowel disease: a Slovak case-control study. United Eur Gastroenterol J. 2013;1(2):109–19.CrossRef
24.
Zurück zum Zitat Packer N, Hoffman-Goetz L. Exercise training reduces inflammatory mediators in the intestinal tract of healthy older adult mice. Can J Aging. 2012;31(2):161–71.CrossRefPubMed Packer N, Hoffman-Goetz L. Exercise training reduces inflammatory mediators in the intestinal tract of healthy older adult mice. Can J Aging. 2012;31(2):161–71.CrossRefPubMed
25.
Zurück zum Zitat Saxena A, Fletcher E, Larsen B, et al. Effect of exercise on chemically-induced colitis in adiponectin deficient mice. J Inflamm (Lond). 2012;9(1):30.CrossRefPubMed Saxena A, Fletcher E, Larsen B, et al. Effect of exercise on chemically-induced colitis in adiponectin deficient mice. J Inflamm (Lond). 2012;9(1):30.CrossRefPubMed
26.
Zurück zum Zitat Lo CH, Khalili H, Song M, et al. Healthy lifestyle is associated with reduced mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2021;19(1):87-95.e4.CrossRefPubMed Lo CH, Khalili H, Song M, et al. Healthy lifestyle is associated with reduced mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2021;19(1):87-95.e4.CrossRefPubMed
27.
Zurück zum Zitat Muñoz-Cánoves P, Scheele C, Pedersen BK, et al. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J. 2013;280(17):4131–48.PubMedCentralCrossRefPubMed Muñoz-Cánoves P, Scheele C, Pedersen BK, et al. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J. 2013;280(17):4131–48.PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Steensberg A, Fischer CP, Keller C, et al. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab. 2003;285(2):E433–7.CrossRefPubMed Steensberg A, Fischer CP, Keller C, et al. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab. 2003;285(2):E433–7.CrossRefPubMed
29.
Zurück zum Zitat Sharif K, Watad A, Bragazzi NL, et al. Physical activity and autoimmune diseases: get moving and manage the disease. Autoimmun Rev. 2018;17(1):53–72.CrossRefPubMed Sharif K, Watad A, Bragazzi NL, et al. Physical activity and autoimmune diseases: get moving and manage the disease. Autoimmun Rev. 2018;17(1):53–72.CrossRefPubMed
30.
Zurück zum Zitat Pittet V, Michetti P, Mueller C, et al. Cohort profile update: the Swiss inflammatory bowel disease cohort study (SIBDCS). Int J Epidemiol. 2019;48(2):385–6.CrossRefPubMed Pittet V, Michetti P, Mueller C, et al. Cohort profile update: the Swiss inflammatory bowel disease cohort study (SIBDCS). Int J Epidemiol. 2019;48(2):385–6.CrossRefPubMed
31.
Zurück zum Zitat Pittet V, Juillerat P, Mottet C, et al. Cohort profile: the Swiss inflammatory bowel disease cohort study (SIBDCS). Int J Epidemiol. 2009;38(4):922–31.CrossRefPubMed Pittet V, Juillerat P, Mottet C, et al. Cohort profile: the Swiss inflammatory bowel disease cohort study (SIBDCS). Int J Epidemiol. 2009;38(4):922–31.CrossRefPubMed
32.
Zurück zum Zitat Piovani D, Danese S, Peyrin-Biroulet L, et al. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology. 2019;157(3):647-59.e4.CrossRefPubMed Piovani D, Danese S, Peyrin-Biroulet L, et al. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology. 2019;157(3):647-59.e4.CrossRefPubMed
33.
Zurück zum Zitat Rasmussen NF, Bech BH, Rubin KH, et al. Associations between participation in, intensity of, and time spent on leisure time physical activity and risk of inflammatory bowel disease among older adults (PA-IBD): a prospective cohort study. BMC Public Health. 2021;21(1):634.PubMedCentralCrossRefPubMed Rasmussen NF, Bech BH, Rubin KH, et al. Associations between participation in, intensity of, and time spent on leisure time physical activity and risk of inflammatory bowel disease among older adults (PA-IBD): a prospective cohort study. BMC Public Health. 2021;21(1):634.PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Steensberg A, Toft AD, Bruunsgaard H, et al. Strenuous exercise decreases the percentage of type 1 T cells in the circulation. J Appl Physiol (1985). 2001;91(4):1708–12.CrossRefPubMed Steensberg A, Toft AD, Bruunsgaard H, et al. Strenuous exercise decreases the percentage of type 1 T cells in the circulation. J Appl Physiol (1985). 2001;91(4):1708–12.CrossRefPubMed
35.
Zurück zum Zitat Huang Y, Chen Z. Inflammatory bowel disease related innate immunity and adaptive immunity. Am J Transl Res. 2016;8(6):2490–7.PubMedCentralPubMed Huang Y, Chen Z. Inflammatory bowel disease related innate immunity and adaptive immunity. Am J Transl Res. 2016;8(6):2490–7.PubMedCentralPubMed
36.
Zurück zum Zitat Winer DA, Luck H, Tsai S, et al. The intestinal immune system in obesity and insulin resistance. Cell Metab. 2016;23(3):413–26.CrossRefPubMed Winer DA, Luck H, Tsai S, et al. The intestinal immune system in obesity and insulin resistance. Cell Metab. 2016;23(3):413–26.CrossRefPubMed
37.
Zurück zum Zitat Balistreri CR, Caruso C, Candore G. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm. 2010;2010: 802078.PubMedCentralCrossRefPubMed Balistreri CR, Caruso C, Candore G. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm. 2010;2010: 802078.PubMedCentralCrossRefPubMed
38.
Zurück zum Zitat Kugathasan S, Nebel J, Skelton JA, et al. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr. 2007;151(5):523–7.CrossRefPubMed Kugathasan S, Nebel J, Skelton JA, et al. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr. 2007;151(5):523–7.CrossRefPubMed
39.
Zurück zum Zitat Jain A, Bricker J, Kappelman MD, et al. Overweight and obese status is not associated with disease activity for children and adolescents with newly diagnosed inflammatory bowel disease. Am J Gastroenterol. 2022;117(7):1146–53.CrossRefPubMed Jain A, Bricker J, Kappelman MD, et al. Overweight and obese status is not associated with disease activity for children and adolescents with newly diagnosed inflammatory bowel disease. Am J Gastroenterol. 2022;117(7):1146–53.CrossRefPubMed
40.
Zurück zum Zitat Bhagavathula AS, Clark CCT, Rahmani J, et al. Impact of body mass index on the development of inflammatory bowel disease: a systematic review and dose-response analysis of 15.6 million participants. Healthcare (Basel). 2021;9:35.PubMedCentralCrossRefPubMed Bhagavathula AS, Clark CCT, Rahmani J, et al. Impact of body mass index on the development of inflammatory bowel disease: a systematic review and dose-response analysis of 15.6 million participants. Healthcare (Basel). 2021;9:35.PubMedCentralCrossRefPubMed
41.
Zurück zum Zitat Akram W, Garud N, Joshi R. Role of inulin as prebiotics on inflammatory bowel disease. Drug Discov Ther. 2019;13(1):1–8.CrossRefPubMed Akram W, Garud N, Joshi R. Role of inulin as prebiotics on inflammatory bowel disease. Drug Discov Ther. 2019;13(1):1–8.CrossRefPubMed
42.
Zurück zum Zitat Thompson NP, Montgomery SM, Wadsworth ME, et al. Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts. Eur J Gastroenterol Hepatol. 2000;12(1):25–30.CrossRefPubMed Thompson NP, Montgomery SM, Wadsworth ME, et al. Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts. Eur J Gastroenterol Hepatol. 2000;12(1):25–30.CrossRefPubMed
44.
Zurück zum Zitat Sonntag B, Stolze B, Heinecke A, et al. Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in life. Inflamm Bowel Dis. 2007;13(11):1385–90.CrossRefPubMed Sonntag B, Stolze B, Heinecke A, et al. Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in life. Inflamm Bowel Dis. 2007;13(11):1385–90.CrossRefPubMed
45.
Zurück zum Zitat Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature. 2012;487(7405):104–8.PubMedCentralCrossRefPubMed Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature. 2012;487(7405):104–8.PubMedCentralCrossRefPubMed
46.
47.
Zurück zum Zitat Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018;67(9):1726–38.CrossRefPubMed Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut. 2018;67(9):1726–38.CrossRefPubMed
48.
Zurück zum Zitat Ananthakrishnan AN, Khalili H, Konijeti GG, et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn’s disease. Gut. 2014;63(5):776–84.CrossRefPubMed Ananthakrishnan AN, Khalili H, Konijeti GG, et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn’s disease. Gut. 2014;63(5):776–84.CrossRefPubMed
49.
Zurück zum Zitat Asfari MM, Sarmini MT, Kendrick K, et al. Association between inflammatory bowel disease and lactose intolerance: fact or fiction. Korean J Gastroenterol. 2020;76(4):185–90.CrossRefPubMed Asfari MM, Sarmini MT, Kendrick K, et al. Association between inflammatory bowel disease and lactose intolerance: fact or fiction. Korean J Gastroenterol. 2020;76(4):185–90.CrossRefPubMed
50.
Zurück zum Zitat Russel MG, Engels LG, Muris JW, et al. Modern life’ in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol. 1998;10(3):243–9.CrossRefPubMed Russel MG, Engels LG, Muris JW, et al. Modern life’ in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol. 1998;10(3):243–9.CrossRefPubMed
51.
Zurück zum Zitat Schütz T, Drude C, Paulisch E, et al. Sugar intake, taste changes and dental health in Crohn’s disease. Dig Dis. 2003;21(3):252–7.CrossRefPubMed Schütz T, Drude C, Paulisch E, et al. Sugar intake, taste changes and dental health in Crohn’s disease. Dig Dis. 2003;21(3):252–7.CrossRefPubMed
52.
Zurück zum Zitat Wang YF, Ou-Yang Q, Xia B, et al. Multicenter case-control study of the risk factors for ulcerative colitis in China. World J Gastroenterol. 2013;19(11):1827–33.PubMedCentralCrossRefPubMed Wang YF, Ou-Yang Q, Xia B, et al. Multicenter case-control study of the risk factors for ulcerative colitis in China. World J Gastroenterol. 2013;19(11):1827–33.PubMedCentralCrossRefPubMed
53.
Zurück zum Zitat Hart AR, Luben R, Olsen A, et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion. 2008;77(1):57–64.CrossRefPubMed Hart AR, Luben R, Olsen A, et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion. 2008;77(1):57–64.CrossRefPubMed
54.
Zurück zum Zitat Ananthakrishnan AN, Khalili H, Song M, et al. High school diet and risk of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2015;21(10):2311–9.PubMed Ananthakrishnan AN, Khalili H, Song M, et al. High school diet and risk of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2015;21(10):2311–9.PubMed
55.
Zurück zum Zitat Chan SS, Luben R, van Schaik F, et al. Carbohydrate intake in the etiology of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2014;20(11):2013–21.CrossRefPubMed Chan SS, Luben R, van Schaik F, et al. Carbohydrate intake in the etiology of Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2014;20(11):2013–21.CrossRefPubMed
56.
Zurück zum Zitat Jantchou P, Morois S, Clavel-Chapelon F, et al. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol. 2010;105(10):2195–201.CrossRefPubMed Jantchou P, Morois S, Clavel-Chapelon F, et al. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol. 2010;105(10):2195–201.CrossRefPubMed
57.
Zurück zum Zitat Vidal-Lletjós S, Beaumont M, Tomé D, et al. Dietary protein and amino acid supplementation in inflammatory bowel disease course: what impact on the colonic mucosa? Nutrients. 2017;9:310.PubMedCentralCrossRefPubMed Vidal-Lletjós S, Beaumont M, Tomé D, et al. Dietary protein and amino acid supplementation in inflammatory bowel disease course: what impact on the colonic mucosa? Nutrients. 2017;9:310.PubMedCentralCrossRefPubMed
58.
Zurück zum Zitat Keeter S, Kennedy C, Michael D, et al. Gauging the impact of growing nonresponse on estimates from a national RDD telephone survey. Public Opin Quart. 2006;70(5):759–79.CrossRef Keeter S, Kennedy C, Michael D, et al. Gauging the impact of growing nonresponse on estimates from a national RDD telephone survey. Public Opin Quart. 2006;70(5):759–79.CrossRef
59.
Zurück zum Zitat Choung RS, Locke GR, Schleck CD, et al. A low response rate does not necessarily indicate non-response bias in gastroenterology survey research: a population-based study. J Public Health. 2013;21(1):87–95.CrossRef Choung RS, Locke GR, Schleck CD, et al. A low response rate does not necessarily indicate non-response bias in gastroenterology survey research: a population-based study. J Public Health. 2013;21(1):87–95.CrossRef
Metadaten
Titel
Lifestyle factors associated with inflammatory bowel disease: data from the Swiss IBD cohort study
verfasst von
Severin A. Lautenschlager
Mamadou Pathé Barry
Gerhard Rogler
Luc Biedermann
Philipp Schreiner
Alexander R. Siebenhüner
Swiss IBD Cohort Study Group
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Gastroenterology / Ausgabe 1/2023
Elektronische ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02692-9

Weitere Artikel der Ausgabe 1/2023

BMC Gastroenterology 1/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.